COMPANY INFO
There are two companies named Centaur with distinct profiles. The first, Centaur Pharmaceuticals Private Limited, was founded in 1978 in Mumbai, India. It has 3,523 employees and operates in the pharmaceutical industry, developing and manufacturing branded formulations and APIs. Its website is www.centaurpharma.com. The second, Centaur Analytics, Inc., was founded in 2014 in the United States. It provides a cognitive technology-based integrated hardware and software platform for real-time monitoring and data analytics of stored crops to reduce harvest spoilage. Its website is centaur.ag.
Centaur Pharmaceuticals Private Limited is a leading player in the pharmaceuticals industry, established in 1871 with headquarters in Mumbai, India. Employing over 3,500 people, Centaur Pharmaceuticals Private Limited focuses on the development and manufacture of branded formulations and APIs, serving a significant segment of the healthcare sector. Their global presence is supported by offices in key regions including Dubai, Dublin, New York, London, and more, reflecting an international footprint and commitment to pharmaceutical innovation and client service worldwide.
Centaur Pharmaceuticals Private Limited has pursued a measured and diverse funding strategy, raising a total of $6.12 million across five rounds. The company’s funding history reflects participation in seed rounds, grants, and conventional debt, supporting everything from early-stage development to product growth and operational financing. Notable milestones include significant early investments from key venture capital investors and winning a prestigious grant from the European Union to support company innovation initiatives. The latest funding activity occurred in November 2020, aligning with Centaur Pharmaceuticals Private Limited's drive for international expansion and research advancement.
This grant was awarded to support company initiatives or innovative projects, helping Centaur Pharmaceuticals Private Limited advance strategic business and R&D goals.
A seed round designed to support early-stage development, aiding in building foundational capabilities and advancing product innovation.
A significant seed round led by Marathon Venture Capital and Detia Degesch, focused on scaling product development and accelerating company growth.
An early seed funding round aimed at initial development activities and company infrastructure building.
A conventional debt round to provide Centaur Pharmaceuticals Private Limited with additional operating capital and financial flexibility.
The European Union played a significant role as a grant provider, supporting Centaur Pharmaceuticals Private Limited’s innovation with prize money for impactful company initiatives.
Marathon Venture Capital is a major venture capital investor, leading the $3M seed round. Their involvement brought strategic support and capital to accelerate Centaur Pharmaceuticals Private Limited's product development and expansion plans.
Detia Degesch co-led a prominent seed round, bringing industry expertise and investment to fuel Centaur Pharmaceuticals Private Limited’s growth within the pharmaceutical sector.
OurCrowd is an influential global investment platform, recognized as a key investor supporting Centaur Pharmaceuticals Private Limited’s funding journey.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Centaur Pharmaceuticals Private Limited funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.